Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 42023-295

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 42023-295). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Daptomycin-spl-structure (Daptomycin 1)

Chemical structure diagram of daptomycin, showing its detailed molecular framework including peptide bonds, amino acid residues, and side chains.*

FDA Label Image

Vial Label Image (Daptomycin 2)

Label for Daptomycin for Injection, 500 mg per vial, lyophilized powder for intravenous use. The single-dose vial must be reconstituted with 10 mL sterile water for injection. Manufactured for Par Health USA, LLC, with storage instructions and lot/expiration placeholders.*

FDA Label Image

500 mg Per Vial X 10 Carton (Daptomycin 3)

Daptomycin for Injection 500 mg per vial in lyophilized powder form for intravenous use. The label indicates the product must be reconstituted with sterile water for injection to a final concentration of 50 mg/mL. Packaging contains ten single-dose vials and instructs to discard unused portions. Manufactured for Endo USA by Par Health USA, LLC, with storage instructions between 2°C to 25°C and no preservatives present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.